ASTMH 2016

American Society of Tropical Medicine and Hygiene (ASTMH), 65th Annual Meeting

November 13 – 17, 2016
Atlanta, Georgia USA
DNDi will be presenting in symposia on sleeping sickness and Chagas disease, as well as co-authoring poster presentations on filarial diseases.


European & Developing Countries Clinical Trials Partnership

November 6-9, 2016
Lusaka, Zambia
Nathalie Strub-Wourgaft, Medical Director, DNDi, will be speaking at the event.

10º ENIFarMed

October 17-18, 2016
São Paulo, Brazil
The 10th ENIFarMed event will focus on access to medicines by exploring public access policies. Joël Keravec, Regional Executive Director of DNDi Latin America will participate in the event.


International Collaborative Research Program for Tackling the NTDs Challenges in African Countries

September 15-16, 2016
Nairobi, Kenya
Monique Wasunna, Director, DNDi Africa and Tatsuro Kuzuki, Scientific Liaison, DNDi Japan presented at the event.

The 7th APS International PharmSci 2016

Pharmaceutical Sciences: Improving World Health

September 5-7, 2016
Glasgow, Scotland
Steve Robinson, Head of Pharmaceutical Development at DNDi, presented on neglected diseases.


XXIV EFMC International Symposium on Medicinal Chemistry

August 28-September 1, 2016
Manchester, UK
Benjamin Perry, Project Manager NTD Drug Discovery Booster, and Charles Mowbray, Head of Drug Discovery, co-authored a poster about the NTD Drug Discovery Booster presented at the symposium.

MedTrop 2016

Doenças urbanas e mundiais

August 21-24, 2016
Maceió, Brazil
DNDi participated in the 52nd Congress of the Brazilian Society of Tropical Medicine.

AIDS 2016

21st International AIDS Conference

July 18-22, 2016
Durban, South Africa
DNDi, CHAI, UNITAID, and NEPHAK held an AIDS 2016 Satellite Session to share practical and programmatic experience developing and introducing new paediatric ARV formulations.

Italian Society of Parasitology Conference

June 21-24, 2016
Bari, Italy
The 29th edition of soIPa National Congress focused on the most important parasitoses of medical and veterinary interest and their impact, particularly in developing countries where poor conditions and lack of economic resources may limit public health policies.

Ivan Scandale, Project Manager, presented on new molecules for parasites.

Population Approach Group Europe (PAGE)

June 7-10, 2016
Lisbon, Portugal
PAGE represents a community with a shared interest in data analysis using the population approach. Each year a meeting is held in June at a different European location. Stephanie Braillard, Project Manager, DNDi and Charles Mowbray, Head of Drug Discovery, DNDi presented a poster at the event.

DNDi Innovation & Access – Partners’ Meeting 2016

June 6-8, 2016
Rio de Janeiro, Brazil
DNDi Latin America organized a series of events with conferences, discussions and meetings. International scientists, product developers, policy-makers, and civil society organizations, participated in the events in order to do the best science for the most neglected.

ISNTD d3 2016

May 25-26, 2016
London, United Kingdom
Eric Chatelain, Head of Drug Discovery, presented on drug discovery and development for Chagas disease.

Global health R&D: What’s at stake during the 69th WHA?

GHTC Panel Discussion

May 23, 2016
Geneva, Switzerland

A lunchtime panel discussion and webinar hosted by the Global Health Technologies Coalition and the Geneva Centre for Security Policy. Bernard Pécoul, Executive Director, DNDi spoke at the event.

Swiss Malaria Group Event: World Malaria Day

April 25, 2016
Bern, Switzerland
The Swiss Malaria Group marked the occasion of World Malaria Day 2016 in Bern. The group informed the public about the commitment of the Swiss Malaria Group Association in the fight against malaria and about the devastation still caused by malaria in the world.

Geneva Health Forum 2016

April 19-21, 2016
Geneva, Switzerland
Carolina Batista, Regional Medical Manager, and Andrea Marchiol, Coordinator for the Chagas Operational Projects, presented on access to treatment for Chagas disease.

The International Liver Congress

April 13-17, 2016
Barcelona, Spain
DNDi launched its new Research & Development Strategy for Hepatitis C at the International Liver Congress (ILC) on April 13th.